Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Advertisement

Springer Nature Link
Log in

Interactions Between Oral Contraceptives and Antifungals/Antibacterials

Is Contraceptive Failure the Result?

  • Current Opinion
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

The effectiveness of oral contraceptives may be impaired by concomitant treatment with antimicrobials. This may occur because of reductions in plasma concentrations of ethinylestradiol by the induction of hepatic metabolism, as for rifampicin (rifampin) and possibly griseofulvin, or in a small percentage of women because of interference with enterohepatic recirculation.

There are no scientific data to support the anecdotal evidence that the concomitant use of combined oral contraceptives and antimicrobials reduces contraceptive efficacy in the majority of women. It has been postulated that there is a subset of women in whom the enterohepatic recirculation of ethinylestradiol plays an important role. In these women the action of an antimicrobial may reduce the efficacy of oral contraceptives by interfering with this mechanism. Studies that have quantitatively examined these effects may have failed to include women from this subset because of the small numbers involved in the studies. On the other hand, there are no good prospective studies comparing contraceptive failure rates between compliant women who use combined oral contraceptives with and without antimicrobials.

All women using combined oral contraceptives should be informed of the very low level of risk of interactions with antimicrobials (probably about 1%) and that it is not possible to identify who may be at risk. Women concerned about this low level of risk should be given information about the use of barrier methods or avoidance of intercourse during the first 7 days of concomitant antimicrobial therapy and for 7 subsequent days. Women who have had previous contraceptive failures or developed breakthrough bleeding during concomitant antimicrobial use should be strongly advised to follow these precautions, as they may be part of the subset of women at higher risk of contraceptive failure.

This is a preview of subscription content,log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from ¥17,985 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price includes VAT (Japan)

Instant access to the full article PDF.

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. Helms SF, Bredle DI, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol 1997 May; 36 (5 Pt 1): 705–10.

    Article PubMed CAS  Google Scholar 

  2. Back DJ, Orme MLE. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet. 1990; 6: 472–84.

    Article  Google Scholar 

  3. Goldzieher JW, Brody SA. Pharmacokinetics of ethinyl estradiol and mestranol. Am J Obstet Gynaecol. 1990; 163: 2114–9.

    CAS  Google Scholar 

  4. Back DJ, Breckenridge AM, Crawford FE, et al. An investigation of the pharmacokinetics of ethinylestradiol in women using radioimmunoassay. Contraception. 1979; 20: 263–73.

    Article PubMed CAS  Google Scholar 

  5. Guengerich PH. Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs. Am J Obstet Gynaecol 1990; 163 (6 Pt 2): 2159–63.

    CAS  Google Scholar 

  6. Orme MLE, Back DI. Factors affecting the enterohepatic circulation of oral contraceptive steroids. Am J Obstet Gynaecol. 1990; 163: 2146–52.

    CAS  Google Scholar 

  7. Fotherby K. Interactions with oral contraceptives. Am J Obstet Gynaecol. 1990; 163: 2153–9.

    CAS  Google Scholar 

  8. Shenfield GM. Oral contraceptives: are drug interactions of clinical significance? Drug Saf 1993; 9(1): 21–37.

    Article PubMed CAS  Google Scholar 

  9. Reimers D, Jezek A. Rifampicin und andere antituberkulostatika bei gleichzeitiger oraler kontrazeption. Praxis Klinik Pneumol. 1981; 25: 255–62.

    Google Scholar 

  10. Orme MLE, Back DJ, Breckenridge AM. Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacol. 1983; 8: 95–136.

    Article CAS  Google Scholar 

  11. Van Dijke CPH, Weber JCR. Interaction between oral contraceptives and griseofulvin. BMJ. 1984; 288: 1125–6.

    Article PubMed  Google Scholar 

  12. Pillans PI, Sparrow MJ. Pregnancy associated with a combined oral contraceptive and itraconazole. NZ Med J. 1993; 208: 408.

    Google Scholar 

  13. van Puijenbroek EP, Feenstra J, Meyboom RH. Pill cycle disturbance in simultaneous use of itraconazole and oral contraceptives. Ned Tijdschr Geneeskd. 1998; 142: 146–9.

    PubMed  Google Scholar 

  14. Stockley IH. Drug interactions. Oxford: Blackwell Science, 1994.

    Google Scholar 

  15. Back DJ, Tija JF. Azoles and allylamines: the clinical implications of interactions with cytochrome P-450 enzymes. J Dermatol Treat. 1990; 1: 11–3.

    Article  Google Scholar 

  16. Sinofsky FE, Pasquale SA. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. Am J Obstet Gynecol. 1998; 178: 300–4.

    Article PubMed CAS  Google Scholar 

  17. Bacon JF, Shenfield GM. Pregnancy attributable to interaction between tetracycline and oral contraceptives. BMJ 1980 Feb 2; 280 (6210): 293.

    Article PubMed CAS  Google Scholar 

  18. Bainton R. Interaction between antibiotic therapy and contraceptive medication. Oral Surg. 1986; 61: 453–5.

    Article PubMed CAS  Google Scholar 

  19. Dossetor J. Drug interactions with oral contraceptives. BMJ. 1975; 4: 467–8.

    Article  Google Scholar 

  20. De Sano EA, Hurley SC. Possible interactions of antihistamines and antibiotics with oral contraceptive effectiveness. Fertil Steril. 1982; 37: 853–4.

    Google Scholar 

  21. Back DI, Grimmer SFM, Orme MLE, et al. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive drug interactions with anticonvulsants and antibiotics. J Clin Pharmacol. 1988; 25: 527–32.

    CAS  Google Scholar 

  22. Sparrow MJ. Pill method failure. NZ Med J. 1987; 100: 102–5.

    CAS  Google Scholar 

  23. Hughes BR, Canliffe WI. Interactions between the oral contraceptive pill and antibiotics [letter]. Br J Dermatol. 1990; 122: 717–8.

    Article PubMed CAS  Google Scholar 

  24. London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral contraceptives. Arch Dermatol. 1994; 130: 392–3.

    Article PubMed CAS  Google Scholar 

  25. Friedman CL, Huneke AL, Kim MH, et al. The effect of ampicillin on oral contraceptive effectiveness. Obstet Gynaecol. 1980; 55: 33–7.

    CAS  Google Scholar 

  26. Murphy AA, Zakur HA, Charache P. The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynaecol. 1991; 164: 28–33.

    CAS  Google Scholar 

  27. Back DJ, Breckenridge AM, Maclver M, et al. The effects of ampicillin on oral contraceptive steroids in women. Br J Clin Pharmacol 1982 Jul; 14: 43–8.

    Article PubMed CAS  Google Scholar 

  28. Grimmer SFM, Allen WL, Back DJ, et al. The effective of cotrimoxazole on oral contraceptive steroids in women. Contraception. 1983; 28: 53–9.

    Article PubMed CAS  Google Scholar 

  29. Meyer B, Müller F, Wessels P, et al. A model to detect interactions between roxithromycin and oral contraceptives. Clin Pharmacol Ther. 1990; 47: 671–4.

    Article PubMed CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sydney Centre for Reproductive Health Research, Family Planning NSW, 328 Liverpool Road, Ashfield, 2131, NSW, Australia

    Edith Weisberg

  2. Department of Obstetrics and Gynaecology, University of Sydney, Sydney, NSW, Australia

    Edith Weisberg

Authors
  1. Edith Weisberg

Corresponding author

Correspondence to Edith Weisberg.

Rights and permissions

About this article

Access this article

Subscribe and save

Springer+
from ¥17,985 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price includes VAT (Japan)

Instant access to the full article PDF.

Advertisement

[8]ページ先頭
©2009-2026 Movatter.jp